Skin ConditionNCT07622160
Efficacy Test of a Moisturizing and Anti-aging Facial Mask
A study testing Hydrating Repairing Mask and Anti-aging Rejuvenating Mask in people with Skin Condition and Skin Hydration, run by TCI Co., Ltd. at 1 site in Taiwan.
Trial summary
The objective of this study is to evaluate the effect of Moisturizing facial mask and Anti-aging facial mask on human skin condition improvement. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Skin Condition, Skin Hydration, Anti Skin Aging
- What is being tested?
- Hydrating Repairing Mask and Anti-aging Rejuvenating Mask
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteTaiwan
- Study dates
- 29 Apr 2026to 31 Jul 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Participants aged 18 years or older
Who cannot join
- Non-voluntary participants.
- Individuals diagnosed by a physician with skin diseases, liver cirrhosis, or chronic renal failure.
- Individuals with known allergies to cosmetics, medications, or foods.
- Pregnant or breastfeeding individuals.
- Individuals taking medications for chronic diseases.
- Students taught or supervised by the principal investigator.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Efficacy Test of a Moisturizing and Anti-aging Facial Mask for Skin Improvement
The objective of this study is to evaluate the effect of Moisturizing facial mask and Anti-aging facial mask on human skin condition improvement.
Read the detailed description
This study is a single-center, self-controlled human trial designed to evaluate the skin beauty effect of Moisturizing facial mask and Anti-aging facial mask.
Healthy adult participants aged above 18 years will be enrolled. Participants will be informed to apply the facial mask on whole face three times per week for 4 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after single use, and after continuous use for 2 and 4 weeks.
- Conditions
- Skin Condition, Skin Hydration, Anti Skin Aging
- Being tested
- Hydrating Repairing Mask, Anti-aging Rejuvenating Mask
- Keywords
- Facial mask, Skin hydration, Anti skin aging, Skin soothing
- Medical subject headings
- Skin Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hydrating Repairing MaskOther
Also called seibella Hydrating Repairing Mask
Applying the facial mask three times per week for a continuous period of 4 weeks
Anti-aging Rejuvenating MaskOther
Also called seibella Anti-aging Rejuvenating Mask
Applying the facial mask three times per week for a continuous period of 4 weeks
| Study group | Role | What they receive |
|---|---|---|
| Hydrating Repairing Mask | Experimental | Not described Receives: Other: Hydrating Repairing Mask |
| Anti-aging Rejuvenating Mask | Experimental | Not described Receives: Other: Anti-aging Rejuvenating Mask |
What is being measured
The primary outcome is the main question the study is designed to answer.
The change of skin hydration
Corneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation. Units: arbitrary Corneometer® units 0-120.
Measured: Change from Baseline skin hydration at 4 weeks
The change of skin redness
Chroma Meter MM500 was utilized to measure face skin redness. Units: a* value
Measured: Change from Baseline skin redness at 4 weeks
The change of skin texture
VISIA Complexion Analysis was utilized to measure skin texture. Units: arbitrary units
Measured: Change from Baseline skin texture at 4 weeks
The change of skin wrinkles
VISIA Complexion Analysis was utilized to measure skin wrinkles. Units: arbitrary units
Measured: Change from Baseline skin wrinkles at 4 weeks
Secondary outcomes (5)
The change of transepidermal water loss (TEWL)
Tewameter® TM300 (CK, Germany) was utilized to measure TEWL. Units: g/hm²
Measured: Change from Baseline TEWL at 4 weeks
The change of skin tone
Chroma Meter MM500 was utilized to measure face skin tone. Units: Individual Typology Angle (ITA°)
Measured: Change from Baseline skin tone at 4 weeks
The change of skin pores
VISIA Complexion Analysis was utilized to measure skin pores. Units: arbitrary units
Measured: Change from Baseline skin pores at 4 weeks
The change of skin elasticity
Skin elasticity (Softplus, Italy) was utilized to measure face skin elasticity. Units: arbitrary units
Measured: Change from Baseline skin elasticity at 4 weeks
The change of skin collagen density
DermaLab® Series SkinLab Combo was utilized to measure skin collagen density. Units: arbitrary units
Measured: Change from Baseline skin collagen density at 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2026
- Study start29 Apr 2026
- Primary completion15 Jun 2026 (estimated)
- Study completion31 Jul 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Skin ConditionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- TCI Co., Ltd.
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Chia-Hua Liang, Ph.D., Principal investigator, Chia Nan University of Pharmacy ＆ Science
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07622160
- Sponsor's protocol ID
- TMANH114-REC056
- Status last verified
- May 2026
- First submitted
- 26 May 2026
- Last updated
- 3 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy Test of a Moisturizing and Anti-aging Facial Mask for Skin Improvement
- ClinicalTrials.gov ID
- NCT07622160
- Acronym / sponsor ID
- TMANH114-REC056
- Conditions
- Skin Condition, Skin Hydration, Anti Skin Aging
- Keywords
- Facial mask, Skin hydration, Anti skin aging, Skin soothing
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 60 participants (actual)
- Lead sponsor
- TCI Co., Ltd.Industry (pharma, biotech, devices)
- Study start
- 29 Apr 2026 (actual)
- Primary completion
- 15 Jun 2026 (estimated)
- Study completion
- 31 Jul 2026 (estimated)
- First posted
- 3 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objective of this study is to evaluate the effect of Moisturizing facial mask and Anti-aging facial mask on human skin condition improvement.
Detailed description
This study is a single-center, self-controlled human trial designed to evaluate the skin beauty effect of Moisturizing facial mask and Anti-aging facial mask.
Healthy adult participants aged above 18 years will be enrolled. Participants will be informed to apply the facial mask on whole face three times per week for 4 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after single use, and after continuous use for 2 and 4 weeks.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Hydrating Repairing Mask | Experimental | Other: Hydrating Repairing Mask |
| Anti-aging Rejuvenating Mask | Experimental | Other: Anti-aging Rejuvenating Mask |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Participants aged 18 years or older
Key exclusion criteria (6 listed)
- Non-voluntary participants.
- Individuals diagnosed by a physician with skin diseases, liver cirrhosis, or chronic renal failure.
- Individuals with known allergies to cosmetics, medications, or foods.
- Pregnant or breastfeeding individuals.
- Individuals taking medications for chronic diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hydrating Repairing MaskAlso: seibella Hydrating Repairing MaskApplying the facial mask three times per week for a continuous period of 4 weeks | Other | Hydrating Repairing Mask |
| Anti-aging Rejuvenating MaskAlso: seibella Anti-aging Rejuvenating MaskApplying the facial mask three times per week for a continuous period of 4 weeks | Other | Anti-aging Rejuvenating Mask |
Primary outcome
The change of skin hydration
Time frame: Change from Baseline skin hydration at 4 weeks
Corneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation. Units: arbitrary Corneometer® units 0-120.
The change of skin redness
Time frame: Change from Baseline skin redness at 4 weeks
Chroma Meter MM500 was utilized to measure face skin redness. Units: a* value
The change of skin texture
Time frame: Change from Baseline skin texture at 4 weeks
VISIA Complexion Analysis was utilized to measure skin texture. Units: arbitrary units
The change of skin wrinkles
Time frame: Change from Baseline skin wrinkles at 4 weeks
VISIA Complexion Analysis was utilized to measure skin wrinkles. Units: arbitrary units
5 secondary outcomes
The change of transepidermal water loss (TEWL)
Time frame: Change from Baseline TEWL at 4 weeks
The change of skin tone
Time frame: Change from Baseline skin tone at 4 weeks
The change of skin pores
Time frame: Change from Baseline skin pores at 4 weeks
The change of skin elasticity
Time frame: Change from Baseline skin elasticity at 4 weeks
The change of skin collagen density
Time frame: Change from Baseline skin collagen density at 4 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2026.
Related trials for Skin Condition
Not yet recruitingPhase 2
Extension Study of Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis (CDDY391A12201-extension)
Moderate to Severe Psoriatic Arthritis
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
RecruitingPhase 2
Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Invasive Mammary Carcinoma, Metastatic Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Chia-Hua Liang, Ph.D. principal investigator
Chia Nan University of Pharmacy ＆ Science
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hydrating Repairing Mask and Anti-aging Rejuvenating Mask in people with Skin Condition and Skin Hydration, run by TCI Co., Ltd. at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The change of skin hydration (time frame: Change from Baseline skin hydration at 4 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.